This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Australian bat lyssavirus | |
|---|---|
| Name | Australian bat lyssavirus |
| Virus group | Mononegavirales |
| Family | Rhabdoviridae |
| Genus | Lyssavirus |
| Genome | Negative-sense single-stranded RNA |
| Hosts | Bats, humans |
| Transmission | Bites, scratches, mucosal exposure |
| Discovery | 1996 |
Australian bat lyssavirus is a zoonotic viral agent in the genus Lyssavirus within the family Rhabdoviridae that causes a rabies-like encephalitis in chiropteran and human hosts. First identified in the 1990s in the region of Australia, the agent has become central to One Health interactions among wildlife agencies, public health authorities, and clinical services in states such as New South Wales, Queensland, Victoria, and the Northern Territory. Cases prompted collaboration involving institutions like the Commonwealth Scientific and Industrial Research Organisation, the Royal Prince Alfred Hospital, and the Australian Department of Health.
The virus is a member of the genus Lyssavirus related to classical Rabies virus and other phylogroups that include species associated with bats such as European bat lyssavirus, Duvenhage virus, and Irkut virus. Its genome is a negative-sense single-stranded RNA encoding the canonical rhabdovirus proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and polymerase (L), similar to isolates characterized by laboratories at the Centers for Disease Control and Prevention, the World Organisation for Animal Health, and university virology departments like the University of Sydney virology unit. Molecular phylogenetics using techniques developed at institutions such as the Broad Institute and the Walter and Eliza Hall Institute place it in phylogroup I/II comparisons that inform antigenic relationships relevant to vaccine cross-protection.
Primary reservoirs are frugivorous and insectivorous bats in Australia, notably species in the families Pteropodidae and Vespertilionidae, including the Pteropus alecto (black flying fox) and other flying foxes documented by researchers at the Australian Museum and the Queensland Government wildlife units. Human infections follow percutaneous exposures like bites and scratches or mucosal contamination; these exposure routes mirror transmission documented in historical rabies outbreaks and in case reports from tertiary hospitals such as Royal Melbourne Hospital and The Alfred. Surveillance programs coordinated by the National Health and Medical Research Council and state health departments track detections in bat populations, sentinel animals, and incidental spillover cases to humans and domestic animals like dogs and horses, with ecological drivers studied in conjunction with researchers at the Australian National University and the CSIRO. Internationally, comparisons are made with bat-associated lyssaviruses reported in Africa, Europe, and Asia.
Human disease presents as an acute progressive encephalomyelitis with prodromal symptoms (fever, malaise) progressing to neuropsychiatric signs, autonomic instability, and paralysis, paralleling clinical syndromes seen in cases of rabies maintained in clinical cohorts at centers like Johns Hopkins Hospital and Mayo Clinic. Diagnostic confirmation relies on detection of viral antigen or RNA in brain tissue or saliva, serology for lyssavirus-neutralizing antibodies, and immunohistochemical staining methods developed in reference laboratories such as the Australian Centre for Disease Preparedness and the Public Health Laboratory Network. Neuroimaging at facilities like Royal Brisbane and Women's Hospital and electrophysiological assessments support clinical evaluation but definitive diagnosis typically uses molecular assays performed in biosafety level 3 or 4 settings affiliated with universities like Monash University.
There is no proven effective antiviral therapy once symptomatic encephalitis is established; management is supportive and intensive care–based as practiced in neurocritical care units at Royal Adelaide Hospital and other tertiary hospitals. Post-exposure prophylaxis (PEP) using human rabies immunoglobulin and rabies vaccine regimens recommended by advisory bodies such as the Australian Technical Advisory Group on Immunisation and the World Health Organization is effective when administered promptly, with vaccine products supplied by pharmaceutical manufacturers and distributed via state immunisation programs. Clinical guidelines from agencies like the Therapeutic Goods Administration guide PEP indications following bat exposures.
Public health responses integrate wildlife management by entities like the Department of Agriculture, Fisheries and Forestry and public communication from state health departments including NSW Health and Queensland Health. Measures include risk assessment of exposures, wound care protocols recommended in emergency departments at hospitals such as St Vincent's Hospital, coordination of rabies vaccine supply chains, and community outreach campaigns modeled after zoonotic control programs run by the World Health Organization and the Food and Agriculture Organization. Occupational guidelines for veterinarians, wildlife handlers, and laboratory personnel are informed by professional bodies such as the Australian Veterinary Association.
The virus was first identified in 1996 following fatal encephalitis in a human and contemporaneous detections in bats, with key investigations conducted by clinicians and virologists at institutions including the University of Melbourne, the Queensland Institute of Medical Research (now QIMR Berghofer Medical Research Institute), and the Australian Centre for Disease Control-aligned laboratories. The discovery prompted national reviews by the National Health and Medical Research Council and stimulated comparative studies with historic lyssavirus findings reported by researchers associated with the Centers for Disease Control and Prevention and European reference centers.
Ongoing research spans molecular epidemiology, vaccine cross-neutralization studies, and ecological surveillance conducted by consortia linking the CSIRO, universities such as University of Queensland and Deakin University, and public health laboratories within the Public Health Laboratory Network. Surveillance employs passive and active sampling of bat colonies with field teams coordinated by wildlife managers at the Department of Environment and Energy and uses next-generation sequencing platforms available at facilities like the Garvan Institute of Medical Research. Collaborative networks with international partners such as the WHO Collaborating Centres and comparative efforts with outbreaks studied by institutions like Pasteur Institute inform risk assessment and mitigation strategies.
Category:Lyssaviruses Category:Zoonoses Category:Viral encephalitis